|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
134,746,000 |
Market
Cap: |
1.63(B) |
Last
Volume: |
3,983,089 |
Avg
Vol: |
3,972,216 |
52
Week Range: |
$10.73 - $14.99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 457 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Dynavax Technologies is a commercial stage biopharmaceutical company engaged in developing and commercializing vaccines. Co.'s primary marketed product, Hepatitis B Vaccine (Recombinant), Adjuvanted (HEPLISAV-B), is approved in the U.S. and European Union for prevention of infection caused by known subtypes of hepatitis B virus in adults age 18 years and older. Co. also manufactures and sells CpG oligonucleotide (CpG) 1018 adjuvant, the vaccine adjuvant used in HEPLISAV-B. Co. developed CpG 1018 adjuvant to provide an increased vaccine immune response.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
3,615 |
34,641 |
2,227,529 |
7,927,750 |
Total Sell Value |
$43,127 |
$457,999 |
$31,224,010 |
$106,100,189 |
Total People Sold |
1 |
4 |
5 |
6 |
Total Sell Transactions |
1 |
4 |
17 |
31 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Macdonald Kelly |
SVP and CFO |
|
2023-02-27 |
4 |
D |
$10.36 |
$30,821 |
D/D |
(2,975) |
2,359 |
|
- |
|
Macdonald Kelly |
SVP and CFO |
|
2023-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,334 |
5,334 |
|
- |
|
Burgess Justin |
Chief Accounting Officer |
|
2023-02-27 |
4 |
S |
$10.32 |
$232,146 |
D/D |
(22,371) |
0 |
|
-22% |
|
Burgess Justin |
Chief Accounting Officer |
|
2023-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,250 |
12,538 |
|
- |
|
Spencer Ryan |
CEO and Director |
|
2023-02-27 |
4 |
D |
$10.36 |
$310,593 |
D/D |
(29,980) |
178,459 |
|
- |
|
Spencer Ryan |
CEO and Director |
|
2023-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
60,472 |
193,132 |
|
- |
|
Janssen Robert |
SVP and CMO |
|
2023-02-27 |
4 |
D |
$10.36 |
$74,343 |
D/D |
(7,176) |
49,925 |
|
- |
|
Janssen Robert |
SVP and CMO |
|
2023-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,584 |
51,706 |
|
- |
|
Novack David F |
President & COO |
|
2023-02-27 |
4 |
D |
$10.36 |
$182,015 |
D/D |
(17,569) |
20,702 |
|
- |
|
Novack David F |
President & COO |
|
2023-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,084 |
29,292 |
|
- |
|
Spencer Ryan |
CEO and Director |
|
2023-02-15 |
4 |
A |
$9.73 |
$17,378 |
D/D |
1,786 |
147,967 |
|
- |
|
Burgess Justin |
Chief Accounting Officer |
|
2023-02-15 |
4 |
A |
$9.73 |
$1,187 |
D/D |
122 |
4,121 |
|
- |
|
Novack David F |
President & COO |
|
2023-02-15 |
4 |
A |
$9.73 |
$10,907 |
D/D |
1,121 |
3,187 |
|
- |
|
Janssen Robert |
SVP and CMO |
|
2023-02-15 |
4 |
A |
$9.73 |
$5,001 |
D/D |
514 |
36,517 |
|
- |
|
Hack Andrew A. F. |
Director |
|
2022-12-06 |
4 |
S |
$11.60 |
$17,400,000 |
I/I |
(1,500,000) |
3,915,000 |
|
5% |
|
Novack David F |
President & COO |
|
2022-11-08 |
4 |
S |
$12.47 |
$650,984 |
D/D |
(52,204) |
2,066 |
|
23% |
|
Spencer Ryan |
CEO and Director |
|
2022-08-15 |
4 |
A |
$10.29 |
$17,164 |
D/D |
1,668 |
146,181 |
|
- |
|
Burgess Justin |
Chief Accounting Officer |
|
2022-08-15 |
4 |
A |
$10.29 |
$1,492 |
D/D |
145 |
3,999 |
|
- |
|
Janssen Robert |
SVP and CMO |
|
2022-08-15 |
4 |
A |
$10.29 |
$4,980 |
D/D |
484 |
36,003 |
|
- |
|
Novack David F |
President & COO |
|
2022-08-15 |
4 |
A |
$10.29 |
$10,877 |
D/D |
1,057 |
54,270 |
|
- |
|
Hack Andrew A. F. |
Director |
|
2022-08-15 |
4 |
S |
$14.68 |
$44,040,000 |
I/I |
(3,000,000) |
5,415,000 |
|
34% |
|
Janssen Robert |
Senior Vice President |
|
2022-08-09 |
4 |
S |
$16.92 |
$134,277 |
D/D |
(7,938) |
35,519 |
|
34% |
|
Novack David F |
President & COO |
|
2022-08-09 |
4 |
S |
$16.92 |
$444,037 |
D/D |
(26,250) |
53,213 |
|
34% |
|
Spencer Ryan |
CEO and Director |
|
2022-08-09 |
4 |
S |
$16.92 |
$252,399 |
D/D |
(14,921) |
144,513 |
|
34% |
|
Janssen Robert |
Senior Vice President |
|
2022-08-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,750 |
43,457 |
|
- |
|
434 Records found
|
|
Page 4 of 18 |
|
|